Cancer symposium for the practitioner: Introduction to solid tumors

Mayo Clinic Proceedings

Volumn 82, Issue 1, 2007, Pages 107-109

  Adjei, Alex A ^a   Rajkumar, S Vincent ^b   Tefferi, Ayalew ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Mayo Clinic College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [6 METHOXY 7 [3 (1 PIPERIDINYL)PROPOXY] 4 QUINAZOLINYL] 1 PIPERAZINECARBOXYLIC ACID (4 ISOPROPOXYPHENYL)AMIDE; 6 [4 (4 ETHYL 1 PIPERAZINYLMETHYL)PHENYL] 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; AP 23573; ARRY 0401; AXITINIB; AZM 475271; BEVACIZUMAB; CARBOPLATIN; CEP 2583; CEP 701; CETUXIMAB; CYCLOPROPANECARBOXYLIC ACID [4 [4 (4 METHYL 1 PIPERAZINYL) 6 (5 METHYL 2H PYRAZOL 3 YLAMINO) 2 PYRIMIDINYLTHIO]PHENYL]AMIDE; DASATINIB; EVEROLIMUS; IMATINIB; N (2,3 DIHYDROXYPROPOXY) 3,4 DIFLUORO 2 (2 FLUORO 4 IODOANILINO)BENZAMIDE; N (3,3 DIMETHYL 6 INDOLINYL) 2 (4 PYRIDINYLMETHYLAMINO)NICOTINAMIDE; OXALIPLATIN; PACLITAXEL; SORAFENIB; SUNITINIB; TEMSIROLIMUS; TRASTUZUMAB; UNCLASSIFIED DRUG; VANDETANIB; VATALANIB;

ANOREXIA; ASTHENIA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONSTIPATION; DIARRHEA; DYSPNEA; EPITHELIUM TUMOR; FATIGUE; GASTROINTESTINAL STROMAL TUMOR; HAND FOOT SYNDROME; HEADACHE; HEMOPTYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY CARCINOMA; NAUSEA; NEUTROPENIA; PROTEINURIA; RASH; SOLID TUMOR; THROMBOCYTOPENIA; THYROID CARCINOMA; VOMITING;

EID: 33845926886     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.1.107     Document Type: Conference Paper

References (51)

1. Tefferi A, Rajkumar SV, Adjei AA. Introduction to a cancer symposium for the practitioner. Mayo Clin Proc. 2005;80:1085-1086.
2. American Cancer Society. Cancer Facts & Figures 2006. Available at: www.cancer.org.
3. Adjei AA, Rowinsky EK. Novel anticancer agents in clinical development. Cancer Biol Ther. 2003;2(4, suppl 1):S5-S15.
4. Segota E, Bukowski RM. The promise of targeted therapy: cancer drugs become more specific. Cleve Clin J Med. 2004;71:551-560.
5. Adjei AA, Hidalgo M. Intracellular signal transduction pathway proteins as targets for cancer therapy. J Clin Oncol. 2005 Aug 10;23:5386-5403. Epub 2005 Jun 27.
6. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001; 411:355-365.
7. Gill S, Blackstock AW, Goldberg RM. Colorectal cancer. Mayo Clin Proc. 2007;82:114-129.
8. Ravandi F, O'Brien S. Chronic lymphoid leukemias other than chronic lymphocytic leukemia: diagnosis and treatment. Mayo Clin Proc. 2005; 80:1660-1674.
9. Jabbour EJ, Faderl S, Kantarjian HM. Adult acute lymphoblastic leukemia. Mayo Clin Proc. 2005;80:1517-1527.
10. Rajkumar SV, Kyle RA. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2005;80:1371-1382.
11. Tefferi A, Barbui T. bcr/abl-negative, classic myeloproliferative disorders: diagnosis and treatment. Mayo Clin Proc. 2005;80:1220-1232.
12. Ansell SM, Armitage J. Non-Hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc. 2005;80:1087-1097.
13. Yee KW, O'Brien SM. Chronic lymphocytic leukemia: diagnosis and treatment. Mayo Clin Proc. 2006;81:1105-1129.
14. Quintas-Cardama A, Cortes JE. Chronic myeloid leukemia: diagnosis and treatment. Mayo Clin Proc. 2006;81:973-988.
15. Halfdanarson TR, Hogan WJ, Moynihan TJ. Oncologic emergencies: diagnosis and treatment. Mayo Clin Proc. 2006;81:835-848.
16. Rajkumar SV, Dispenzieri A, Kyle RA. Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment. Mayo Clin Proc. 2006;81:693-703.
17. Tefferi A, Elliott MA, Pardanani A. Atypical myeloproliferative disorders: diagnosis and management. Mayo Clin Proc. 2006;81:553-563.
18. Ansell SM, Armitage JO. Management of Hodgkin lymphoma. Mayo Clin Proc. 2006;81:419-426.
19. Jabbour EJ, Estey E, Kantarjian HM. Adult acute myeloid leukemia. Mayo Clin Proc. 2006;81:247-260.
20. Steensma DP, Bennett JM. The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc. 2006;81:104-130.
21. Rajkumar SV. Thalidomide therapy and deep venous thrombosis in multiple myeloma. Mayo Clin Proc. 2005;80:1549-1551.
22. Trieu Y, Trudel S, Pond GR, et al. Weekly cyclophosphamide and alternate-day prednisone: an effective, convenient, and well-tolerated oral treatment for relapsed multiple myeloma after autologous stem cell transplantation. Mayo Clin Proc. 2005;80:1578-1582.
23. Baz R, Li L, Kottke-Marchant K, et al. The role of aspirin in the prevention of thrombotic complications of thalidomide and amhracycline-based chemotherapy for multiple myeloma. Mayo Clin Proc. 2005;80:1568-1574.
24. Parambil JG, Aughenbaugh GL, Pereira TC, Gillespie DJ, Ryu JH. Solitary pulmonary metastasis presenting 20 years after primary resection of Wilms tumor. Mayo Clin Proc. 2005;80:1514-1516.
25. Ecker RD, Endo T, Wetjen NM, Krauss WE. Diagnosis and treatment of vertebral column metastases. Mayo Clin Proc. 2005;80:1177-1186.
26. Bundrick JB, Cook DA, Gostout BS. Screening for cervical cancer and initial treatment of patients with abnormal results from papanicolaou testing. Mayo Clin Proc. 2005;80:1063-1068.
27. Routh JC, Leibovich BC. Adenocarcinoma of the prostate: epidemiological trends, screening, diagnosis, and surgical management of localized disease. Mayo Clin Proc. 2005;80:899-907.
28. Pisansky TM. External beam radiotherapy as curative treatment of prostate cancer. Mayo Clin Proc. 2005;80:883-898.
29. Burke JP, Hay ID, Dignan F, et al. Long-term trends in thyroid carcinoma: a population-based study in Olmsted County, Minnesota, 1935-1999. Mayo Clin Proc. 2005;80:753-758.
30. Steensma DP, List AF. Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity. Mayo Clin Proc. 2005;80:681-698.
31. Batsis JA, Morgenthaler TI. Trousseau syndrome and the unknown cancer: use of positron emission tomographic imaging in a patient with a paraneoplastic syndrome. Mayo Clin Proc. 2005;80:537-540.
32. Tefferi A, Dewald GW, Litzow ML, et al. Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment. Mayo Clin Proc. 2005;80:390-402.
33. Tefferi A. The indolent natural history of essential thrombocythemia: a challenge to new drug development. Mayo Clin Proc. 2005;80:97-98.
34. Tefferi A. Blood eosinophilia: a new paradigm in disease classification, diagnosis, and treatment. Mayo Clin Proc. 2005;80:75-83.
35. Rhodes DJ, O'Connor MK, Phillips SW, Smith RL, Collins DA. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clin Proc. 2005;80: 24-30.
36. Kahlenborn C, Modugno F, Potter DM, Severs WB. Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clin Proc. 2006;81:1290-1302.
37. Cerhan JR. Oral contraceptive use and breast cancer risk: current status. Mayo Clin Proc. 2006;81:1287-1289.
38. Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc. 2006;81:1241-1257.
39. Kademani D, Koka S, Lacy MQ, Rajkumar SV. Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy. Mayo Clin Proc. 2006;81:1100-1103.
40. Lacy MQ, Dispenzieri A, Gertz MA, et al. Mayo Clinic consensus statement for the use of bisphosphonates in multiple myeloma. Mayo Clin Proc. 2006;81:1047-1053.
41. Vesole DH, Pérez WS, Akasheh M, Boudreau C, Reece DE, Bredeson CN. High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study. Mayo Clin Proc. 2006;81:880-888.
42. Lacy MQ. Multiple myeloma: new options, new challenges. Mayo Clin Proc. 2006;81:877-879.
43. Gertz MA. Autologous attack on amyloidosis. Mayo Clin Proc. 2006;81:874-876.
44. Sideras K, Schaefer PL, Okuno SH, et al. Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial. Mayo Clin Proc. 2006;81:758-767.
45. Chandra V, Allen MS, Nichols FC III, Deschamps C, Cassivi SD, Pairolero PC. The role of pulmonary resection in small cell lung cancer. Mayo Clin Proc. 2006;81:619-624.
46. Liang KV, Sanderson SO, Nowakowski GS, Arora AS. Metastatic malignant melanoma of the gastrointestinal tract. Mayo Clin Proc. 2006;81:511-516.
47. Cummins DL, Cummins JM, Pantle H, Silverman MA, Leonard AL, Chanmugam A. Cutaneous malignant melanoma. Mayo Clin Proc. 2006;81: 500-507.
48. Mauro MJ, Maziarz RT. Stem cell transplantation in patients with chronic myelogenous leukemia: when should it be used? Mayo Clin Proc. 2006;81:404-416.
49. Tefferi A. Iron chelation therapy for myelodysplastic syndrome: if and when. Mayo Clin Proc. 2006;81:197-198.
50. Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc. 2006;81:159-166.
51. Campbell PJ, Green AR. The long-term outlook for essential thrombocythemia. Mayo Clin Proc. 2006;81:157-158.